Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) EBIT Margin: 2009-2025

Historic EBIT Margin for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to -9.95%.

  • Rockwell Medical's EBIT Margin fell 1678.00% to -9.95% in Q3 2025 from the same period last year, while for Sep 2025 it was -6.37%, marking a year-over-year decrease of 695.00%. This contributed to the annual value of 0.60% for FY2024, which is 858.00% up from last year.
  • As of Q3 2025, Rockwell Medical's EBIT Margin stood at -9.95%, which was down 18.48% from -8.39% recorded in Q2 2025.
  • Rockwell Medical's 5-year EBIT Margin high stood at 6.84% for Q3 2024, and its period low was -54.52% during Q4 2021.
  • Moreover, its 3-year median value for EBIT Margin was -7.19% (2025), whereas its average is -5.28%.
  • Its EBIT Margin has fluctuated over the past 5 years, first soared by 4,434bps in 2022, then tumbled by 1,678bps in 2025.
  • Quarterly analysis of 5 years shows Rockwell Medical's EBIT Margin stood at -54.52% in 2021, then skyrocketed by 4,434bps to -10.18% in 2022, then spiked by 770bps to -2.48% in 2023, then surged by 37bps to -2.10% in 2024, then slumped by 1,678bps to -9.95% in 2025.
  • Its last three reported values are -9.95% in Q3 2025, -8.39% for Q2 2025, and -7.19% during Q1 2025.